KEAT stimulator
Deviceelectrical stimulation with KEAT stimulator : 4 times per week during 2 months
NCT Number: NCT01276340
The investigators performed a prospective analysis of 450 women with stress, urge and mixed incontinence in order to assess the health-related quality of life (Contilife® questionnaire) and the objective cure rate after two months of electrical stimulation (Keat® stimulator). Management of urinary incontinence with the Keat® stimulator could given an improvement in the quality of life and a good rate of satisfaction without side effect.
Objective cure is as good as subjective improvement especially in urinary stress incontinence. Keat® stimulator is a non-invasive and simple new technique that could be the bew first-line non surgical treatment for female urinary incontinence.
Looking for future studies?
Notify Me18 year and older
Female
Observational
CHU de Clermont-Ferrand, Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
electrical stimulation with KEAT stimulator : 4 times per week during 2 months
Time frame: 2 months
Change from baseline in quality of life after 2 months of electrostimulation Measurement of health-related quality of life with "contilife" questionnaire
Time frame: 2 months
Change from baseline in urinary handicap after 2 months of electr-st-imulation. Measurement of urinary handicap with "MHU" questionnaire
Time frame: 2 months
description of patient's satifaction 2 months after electrostimulation by satisfaction questionaire
Centre Hospitalier Universitaire de Saint Etienne
Other
Prospective Evaluation of Keat Electrostimulator in the Auto-reeducation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06389838
Female Urinary Stress Incontinence, Female Urogenital Diseases
Mainz, Germany
View Trial DetailsNCT05312047
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Badalona, Barcelona, Spain
View Trial DetailsNCT04237753
Adherence Interventions, Behavior
Birmingham, Alabama, United States
View Trial DetailsNCT03166150
Atrophy, Behavior
Washington D.C., District of Columbia, United States
View Trial Details